Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Geoffrey Gurtner Stories

2013-10-15 12:32:50

MENLO PARK, Calif., Oct. 15, 2013 /PRNewswire/ -- Neodyne Biosciences, Inc., announced today that Geoffrey Gurtner, MD, FACS, of Stanford University and Ali Mosharrafa, MD, of Phoenix, AZ will present their clinical experience with the embrace(®) Advanced Scar Therapy device at the Annual Meeting of the American Society of Plastic Surgery (ASPS). embrace(® )Advanced Scar Therapy is rated highly by physicians and patients and stands alone as the only scar management technology proven...

2011-12-12 12:49:52

Researchers at the Stanford University School of Medicine report that they have identified the molecular pathway through which physical force contributes to scarring in mice. "Our study exposes one of the fundamental mechanisms by which the mechanical environment can directly increase inflammation, which is strongly implicated in scarring," said Geoffrey Gurtner, MD, professor and associate chair of surgery. Mice genetically engineered to lack an enzyme that is activated by mechanical...

2011-08-29 12:59:19

Reconnecting severed blood vessels is mostly done the same way today – with sutures – as it was 100 years ago, when the French surgeon Alexis Carrel won a Nobel Prize for advancing the technique. Now, a team of researchers at the Stanford University School of Medicine has developed a sutureless method that appears to be a faster, safer and easier alternative. In animal studies, a team led by Stanford microsurgeon Geoffrey Gurtner, MD, used a poloxamer gel and bioadhesive rather...

2009-07-30 06:26:11

A drug used to remove iron from the body could help doctors fight one of diabetes' cruelest complications -- poor wound healing -- which can lead to infection and amputation. The drug deferoxamine helped diabetic mice heal small cuts 10 days faster than those who did not receive treatment, according to researchers from Stanford University School of Medicine and the Albert Einstein College of Medicine. The team is now working to arrange human trials for deferoxamine. If the results translate,...